Health Care & Life Sciences » Biotechnology | Stemcell United Ltd.

Stemcell United Ltd. | Income Statement

Fiscal year is July-June. All values AUD Thousands.
2015
2016
2017
2018
Sales/Revenue
-
74.80
31.60
290.70
Cost of Goods Sold (COGS) incl. D&A
-
343.30
302.40
738.50
Gross Income
-
268.60
270.80
447.80
SG&A Expense
1,009.20
738.90
936.40
1,462.60
EBIT
1,009.20
1,945.40
1,207.10
1,910.50
Unusual Expense
76,172.50
33,559.60
2,456.30
1,445.40
Non Operating Income/Expense
-
10.20
35.30
-
Interest Expense
128.90
110.00
3.00
-
Pretax Income
75,041.20
35,604.70
3,631.10
3,353.40
Income Tax
-
13.60
-
-
Consolidated Net Income
75,041.20
35,618.40
3,631.10
3,353.40
Net Income
75,041.20
35,618.40
3,631.10
3,353.40
Net Income After Extraordinaries
75,041.20
35,618.40
3,631.10
3,353.40
Net Income Available to Common
75,041.20
35,618.40
3,631.10
3,353.40
EPS (Basic)
0.56
0.09
0.01
0.01
Basic Shares Outstanding
134,526.50
376,861.60
410,462.40
438,032
EPS (Diluted)
0.53
0.09
0.01
0.01
Diluted Shares Outstanding
141,327.50
376,861.60
410,462.40
438,032
EBITDA
1,009.20
1,922.10
1,096.10
1,808
Other Operating Expense
-
937.90
-
-
Non-Operating Interest Income
6.80
-
-
2.50

About Stemcell United

View Profile
Address
680 George Street
Sydney New South Wales (NSW) 2000
Australia
Employees -
Website http://www.scu.com.sg
Updated 07/08/2019
Stemcell United Ltd. engages on using stem cell technology to grow and extract plant essence. It sells Reina Draco and other traditional medicines. It operates through the Australia and Singapore segments.